Lee Sang-heon, CEO of OSCOTECInc: "₩2.5B investment led to ₩1.5T L/O achievement, proven through new drug"
Predicted impact: Low
CEO interview recapping an earlier licensing deal; no new terms disclosed.
039200 · KOSDAQ · ₩039200 · 오스코텍
Predicted impact: Low
CEO interview recapping an earlier licensing deal; no new terms disclosed.
Predicted impact: Low
Also known as: OSCOTECInc / 오스코텍 / 039200 / KRX:039200
Source: KRX statistical information